000 01883 a2200529 4500
005 20250517161843.0
264 0 _c20171031
008 201710s 0 0 eng d
022 _a1538-7445
024 7 _a10.1158/0008-5472.CAN-16-3565
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRicher, Amanda L
245 0 0 _aWEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non-Small Cell Lung Cancer.
_h[electronic resource]
260 _bCancer research
_c09 2017
300 _a4663-4672 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAMP-Activated Protein Kinases
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCell Cycle Checkpoints
_xdrug effects
650 0 4 _aCell Cycle Proteins
_xantagonists & inhibitors
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aMutation
_xgenetics
650 0 4 _aNuclear Proteins
_xantagonists & inhibitors
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProtein Serine-Threonine Kinases
_xdeficiency
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xgenetics
650 0 4 _aPyrazoles
_xpharmacology
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aPyrimidinones
650 0 4 _aTumor Cells, Cultured
700 1 _aCala, Jacqueline M
700 1 _aO'Brien, Kelley
700 1 _aCarson, Vashti M
700 1 _aInge, Landon J
700 1 _aWhitsett, Timothy G
773 0 _tCancer research
_gvol. 77
_gno. 17
_gp. 4663-4672
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-16-3565
_zAvailable from publisher's website
999 _c27314088
_d27314088